InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: Drakon 642 post# 182757

Sunday, 05/21/2017 7:17:50 PM

Sunday, May 21, 2017 7:17:50 PM

Post# of 403170
Brilacidin is an amazing drug in it's antibacterial and anti inflammatory uses.

It's usage in the prevention of severe Oral Mucositis is particularly exciting to me.

http://www.cellceutix.com/press-release/2017/4/8/cellceutix-ceo-discusses-brilacidin-following-interim-trial-results-exceeding-expectations-for-treating-oral-mucositis-and-inflammatory-bowel-disease

According to the preliminary interim results from the trial, only 2 of 9 patients (22.2%) on Brilacidin-OM therapy developed severe OM, defined as Grade 3 or Grade 4 on the World Health Organization (WHO) OM Grading Scale. Patients in the placebo-treated control arm developed severe OM at a much higher rate, with 7 of 10 patients (70%) progressing to that condition. There are now an additional 11 patients active in the trial and more are added weekly.











In Reply to 'Drakon 642'
New blog on Brilacidin on $ctix site:

http://www.cellceutix.com/new-blog/2017/6/5/brilacidins-potential-application-in-dermatology






To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News